[go: up one dir, main page]

PE20010588A1 - Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas - Google Patents

Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas

Info

Publication number
PE20010588A1
PE20010588A1 PE2000000930A PE0009302000A PE20010588A1 PE 20010588 A1 PE20010588 A1 PE 20010588A1 PE 2000000930 A PE2000000930 A PE 2000000930A PE 0009302000 A PE0009302000 A PE 0009302000A PE 20010588 A1 PE20010588 A1 PE 20010588A1
Authority
PE
Peru
Prior art keywords
unit
alkyl
mod
alkylene
linked
Prior art date
Application number
PE2000000930A
Other languages
English (en)
Inventor
Scott Edward Osborne
Todd Laurence Underiner
Timothy Bates
Renae Dianna Fossum
Garry Steven Garrett
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20010588A1 publication Critical patent/PE20010588A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

SE REFIERE A UN CONJUGADO POLIMERICO DE FORMULA [[[MOD]-(X)a-C(=O)-(X)a]w-T]x[(L)z-[POLI]]y QUE COMPRENDE UN COMPONENTE POLIMERICO ENLAZADO A UN COMPONENTE INHIBIDOR DE ENZIMAS QUE TIENE UNA UNIDAD DE ACILO, AMBOS COMPONENTES SE ENLAZAN POR MEDIO DE UNA UNIDAD DE ENLACE CAPAZ DE MODULAR LA INTERACCION ENTRE UNA ENZIMA Y EL COMPONENTE INHIBIDOR, AMBOS COMPONENTES PERMANECEN ENLAZADOS DESPUES QUE DICHA UNIDAD DE ACILO INTERACTUA CON DICHA ENZIMA; DONDE [POLI] ES UNA UNIDAD POLIMERICA: R19(OR18)x, ENTRE OTROS; L ES UN ENLACE CO, CONH, CONHCO, ENTRE OTROS, UNA UNIDAD DE ACILO DE FORMULA [MOD](X)aC(X)(X)a, [MOD] ES H, ALQUILO C1-C18, CICLOALQUILO C3-C18, ALQUENILO C2-C18, SE UNE A LA UNIDAD T PARA FORMAR UN ANILLO C1-C5, UN GRUPO a, b; R ES H, ALQUILO C1-C18, CICLOALQUILO C3-C18, ALQUENILO C2-C18, ALQUINILO C2-C18, ARILO C6-C18, HETEROCICLO C2-C18, ALQUILENOARILO -(R1)n-(R2), (CH2)mN(R3)2, ENTRE OTROS; R1 ES ALQUILENO C1-C12, ALQUENILENO C2-C12, R2 ES ARILO C6-C18, n ES 1-16; R3 ES ALQUILO C1-C18, m ES 0-10, ENTRE OTRAS; X ES CH2, NH, O, S, CF2, a ES 0-1, w ES 1-6, x ES 1-50, y ES 1-10, z ES 0-1, R18 ES ALQUILENO C2-C12, FENILENO, ALQUILENOARILENO C7-C12, ENTRE OTROS. EL CONJUGADO POLIMERICO INHIBE LAS ENZIMAS PROTEASA Y LIPASA UTILES EN EL TRATAMIENTO DE SARPULLIDO DE PANAL
PE2000000930A 1999-09-10 2000-09-08 Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas PE20010588A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15347399P 1999-09-10 1999-09-10

Publications (1)

Publication Number Publication Date
PE20010588A1 true PE20010588A1 (es) 2001-06-23

Family

ID=22547365

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000930A PE20010588A1 (es) 1999-09-10 2000-09-08 Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas

Country Status (6)

Country Link
EP (1) EP1212098A2 (es)
JP (1) JP2003509538A (es)
AR (1) AR023272A1 (es)
AU (1) AU7127000A (es)
PE (1) PE20010588A1 (es)
WO (1) WO2001018181A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5020451B2 (ja) * 1999-09-10 2012-09-05 ザ プロクター アンド ギャンブル カンパニー 酵素インヒビター
RU2324696C2 (ru) * 2001-08-30 2008-05-20 Ализайм Терапевтикс Лимитед Тиено-(1,3)-оксазин-4-оны, обладающие ингибирующей активностью по отношению к липазе
US8907154B2 (en) 2001-10-01 2014-12-09 The Procter & Gamble Company Sanitary napkins with hydrophobic lotions
US20030143186A1 (en) * 2001-11-13 2003-07-31 The Procter & Gamble Company Protease enzyme inhibitors
EA009368B1 (ru) * 2001-12-20 2007-12-28 Оси Фармасьютикалз, Инк. Соединения-ингибиторы липазы поджелудочной железы, их синтез и применение
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
US20050048105A1 (en) * 2003-08-29 2005-03-03 Mcnulty Amy K. Protease inhibitor compositions for prevention and treatment of skin conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
ID28814A (id) * 1998-03-12 2001-07-05 Procter & Gamble Benda penyerap sekali pakai yang mempunyai komposisi perawatan kulit yang dilapisi penghambat enzim
US6066673A (en) * 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
JP2002505917A (ja) * 1998-03-12 2002-02-26 ザ、プロクター、エンド、ギャンブル、カンパニー 吸収性物品中のプロテアーゼインヒビタ
JP2003508480A (ja) * 1999-09-10 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 酵素インヒビター

Also Published As

Publication number Publication date
EP1212098A2 (en) 2002-06-12
AU7127000A (en) 2001-04-10
JP2003509538A (ja) 2003-03-11
WO2001018181A2 (en) 2001-03-15
WO2001018181A3 (en) 2001-12-13
AR023272A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
DE50210382D1 (de) Alkalische protease-varianten und wasch- und reinigungsmittel enthaltend diese alkalischen protease-varianten
PE20010588A1 (es) Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas
PE20000054A1 (es) Derivados de 3-piperidil-4-oxoquinazolina y composiciones farmaceuticas que comprenden los mismos
CO5050310A1 (es) Composiciones desinfectantes y procesos para desinfectar superficies cesos para desinfectar superficies
TR200001729T2 (tr) Zincir ortasından dallanmış yüzeyaktif maddeler içeren granül halinde deterjan terkipleri.
ES2123065T3 (es) Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
CO5070716A1 (es) Composiciones liquidas para la limpieza de superficies duras las cuales contienen un ingrediente antienmugrante
ATE306541T1 (de) Flüssige zusammensetzung
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
AR024837A1 (es) Derivados de n-(iminometil)aminas, compuestos intermediarios para su preparacion, medicamento y composicion farmaceutica que los contienen y uso de dichos derivados para la produccion de medicamentos.
RU95106996A (ru) Сульфонилалканоиламино-гидроксиэтиламино-сульфонамидные соединения, фармацевтические композиции и способы лечения и ингибирования ретровирусных протеаз
AR070081A2 (es) Proceso para el tratamiento del lavado domestico de un material de fibras textiles
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
WO2001040180A3 (en) N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
ES2148808T3 (es) Nuevos compuestos y sus composiciones que tienen actividades anti-inflamatorias y anti-tromboticas.
ATE500322T1 (de) Perhydrolase
ID28314A (id) Komposisi-komposisi pencuci dan pembersih
ES2103488T3 (es) N-(alcanoilamino-2-hidroxipropil)sulfonamidas utiles como inhibidores de proteasas retrovirales.
PT1039912E (pt) Agentes angiostaticos e composicoes para tratar glaucoma glc1a
AR044561A1 (es) Derivados de estatina
BR9910151A (pt) Composições detergentes de lavanderia e/ou para o cuidado de tecidos compreendendo uma enzima modificada
BR9910147A (pt) Composições detergentes de lavagem e/ou para proteção de tecidos compreendendo uma transferase modificada
BR0014151A (pt) Componentes para formulação estável, composições e métodos de lavagem de roupas empregando as mesmas
AR039562A1 (es) Compuestos oxo-azabiciclicos
EA200001197A1 (ru) Усиление активности оксазолидиноновых антибактериальных агентов в результате применения производных аргинина

Legal Events

Date Code Title Description
FX Voluntary withdrawal